We're Attending the International ME/CFS Conference 2026 in Berlin
Share
Oxaloacetate CFS will be attending the International ME/CFS Conference 2026, taking place on 7–8 May 2026 as a hybrid scientific event broadcast from Berlin, Germany.
Hosted at the Harnack House and organised under the leadership of the Carmen Scheibenbogen at Charité – Universitätsmedizin Berlin, the conference brings together international experts working on ME/CFS and post-COVID syndrome.
The two-day event focuses on the latest research into disease mechanisms and clinical trials, covering areas such as immune dysfunction, metabolic pathways, biomarkers, and new treatment approaches. Day two is dedicated entirely to clinical trial data, with additional sessions highlighting ongoing research in Germany.
Oxaloacetate CFS’s CEO Alan Cash will be present at the conference alongside other global researchers and clinicians contributing to the evolving understanding of ME/CFS and related post-viral conditions.
Presentations will be streamed live and recordings will be made publicly available after the event.